Top Pharmaceuticals companies in Saudi Arabia by EBIT Margin

This ranking features the top 12 Pharmaceuticals companies in Saudi Arabia ranked by EBIT Margin, averaging a EBIT Margin of 11.72%, for February 11, 2025.
#
Name
EBIT Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
30.59%
Dec. 31, 2023 USD 21.05 -0.14%

Saudi Arabia

2
29.47%
Dec. 31, 2023 USD 11.78 0.56%

Saudi Arabia

3
28.21%
Dec. 31, 2023 USD 23.45 0.11%

Saudi Arabia

4
23.47%
Dec. 31, 2023 USD 79.10 0.92%

Saudi Arabia

5
18.59%
Dec. 31, 2023 USD 49.78 -0.32%

Saudi Arabia

6
17.20%
Dec. 31, 2023 USD 41.57 0.76%

Saudi Arabia

7
13.54%
Dec. 31, 2023 USD 26.12 4.04%

Saudi Arabia

8
11.77%
Dec. 31, 2023 USD 31.77 0.11%

Saudi Arabia

9
6.43%
Dec. 31, 2023 USD 2.78 -0.08%

Saudi Arabia

10
5.77%
Dec. 31, 2023 USD 8.86 0.11%

Saudi Arabia

11
2.54%
Dec. 31, 2023 USD 14.82 -1.49%

Saudi Arabia

12
-46.94%
Dec. 31, 2023 USD 4.61 2.97%

Saudi Arabia

Frequently Asked Questions
  • Which Pharmaceuticals company in Saudi Arabia has the highest EBIT Margin ?

    The Pharmaceuticals company in Saudi Arabia with the highest EBIT Margin is Naba Alsaha Medical Services Company (Saudi Stock Exchange: 9546.SR) at 30.59%.

  • Which Pharmaceuticals company in Saudi Arabia has the lowest EBIT Margin ?

    The Pharmaceuticals company in Saudi Arabia with the lowest EBIT Margin is Ayyan Investment Company (Saudi Stock Exchange: 2140.SR) at -46.94%.

SV Wall Street